Promote the standardized development of blood diseases and improve the level of diagnosis and treatment of blood diseases
11, 2022 /PRNewswire/ -- At the intersection of autumn and winter, orange-yellow-orange-green hours
On November 4-5, 2022, the "2022 Academic Annual Conference of the Hematology Professional Committee of the China Association of Non-public Medical Institutions" was successfully held
online, hosted by the Hematology Professional Committee of the China Association of Non-public Medical Institutions (hereinafter referred to as the "Association"), co-hosted by the Beijing Health Promotion Association, and undertaken by the Beijing Lu Daopei Institute of Hematology.
Nearly 3,000 well-known experts and scholars in the field of hematology in China gathered online to exchange the latest scientific research results and discuss hot topics
in the industry.
The conference gathers academic resources and exchanges academic talents
The exchange of knowledge and the collision of wisdom brought a feast of ideas and academic feasts
to the participants.
Guest speech at the 2022 Academic Annual Conference of the Hematology Professional Committee of China Association of Non-public Medical Institutions
- Promote the scientific and standardized development of blood diseases in China
Hao Deming, executive vice president and secretary general and founder of the association, Lu Peihua, chairman of the special committee and executive medical director of Lu Daopei Hospital, Professor Liu Kaiyan, vice chairman of the special committee and executive vice president of Beijing Lu Daopei Institute of Hematology, and Professor Zhang Bolong, consultant of the special committee and secretary general of the conference, attended the opening ceremony and delivered speeches
The opening ceremony was presided over
by Professor Zhang Fengchun, Vice Chairman of the Special Committee and Suzhou Jiulong Hospital affiliated to Shanghai Jiao Tong University School of Medicine.
President Hao Deming delivered a speech
President Hao Deming fully affirmed the positive contributions
made by the Hematology Committee since its establishment to promoting the scientific and standardized development of hematology in China, helping to build and improve the scientific and technological innovation system of hematology in China, effectively improving the diagnosis and treatment of difficult blood diseases, and promoting the prevention and treatment of hematology in China.
He hoped that the special committee would continue to play its role as an industry organization, work hard, forge ahead, deepen its roots in the field of blood diseases, and jointly make unremitting efforts
to build a healthy China and promote the sustainable and healthy development of China's blood diseases.
Chairman Lu Peihua delivered a speech
Chairman Lu Peihua first welcomed and thanked
the experts and scholars attending the meeting, the vice chairmen of the special committee, the standing committee, members and members.
She said that social medical service is an important part and an important force in China's medical and health service system, and a new engine
for the development of the medical industry.
Everyone should unite as one, run medical services in good faith, share resources related to the diagnosis and treatment of hematological diseases and tumors, jointly shout for the large-scale development of social medical services, cheer for promoting academic exchanges in the industry, and contribute due strength
to the progress and development of China's hematological cause.
Professor Liu Kaiyan delivered a speech
Professor Liu Kaiyan said that under the leadership of Chairman Lu Peihua, the special committee has made great progress and achieved very remarkable results
The experts and speakers invited by this academic conference will introduce the clinical experience and cutting-edge progress in various aspects of blood disease diagnosis, treatment and testing from different perspectives, and hope that everyone can gain
Speech by Secretary General of the Conference
On behalf of the Special Committee, Secretary General Zhang Bolong expressed his gratitude to the General Association, President Hao Deming and members of the Special Committee for their guidance, concern, support and participation in the work of the Special Committee, and hoped that through this academic annual meeting, the academic capacity building of the Special Committee can be further improved and social influence
can be enhanced.
- Exchange the latest scientific research results and exchange hot topics in the industry
In the academic report session, more than 30 experts and scholars in the field of hematology from all over the country were invited to focus on the current situation and latest progress in the diagnosis and treatment of hematological tumors at home and abroad, covering the progress of CAR-T therapy, hematopoietic stem cell transplantation, the diagnosis and treatment of lymphoma and myeloma, the diagnosis and treatment of related complications and the clinical nutrition of patients, and discussed the corresponding cases and exchanged experience
Academic Report Session 1
President Lu Peihua made a report
Based on clinical cases and the latest research, President Lu Peihua quoted the BLOOD review article "CAR-T Spear and Shield" as a report
entitled "Opportunities and Challenges of CD7 CAR-T in the Treatment of T Cell Malignant Tumors".
Director Wang Hui made a report
Wang Hui, director of Lu Daopei Hospital, interpreted the flow cytometry aspects of the WHO diagnostic criteria for hematopoiesis and lymphoma in 2022
Professor Fan Min gave a report
Professor Fan Min, Chairman of the Clinical Nutrition Professional Committee of the Association and Xinjiang Uygur Autonomous Region People's Hospital, emphasized the important role
of nutrition therapy in the report "Clinical Nutrition Therapy for the Prevention and Treatment of Chemotherapy Complications of Hematological Diseases".
Moderator and panelists: Prof.
Zhang Bolong, Prof.
Meng Fanyi, Prof.
Academic Report Session 2
Professor Huang Zhongxia gave a speech
Professor Huang Zhongxia of Beijing Chaoyang Hospital affiliated to Capital Medical University shared his valuable experience and experience in the treatment of MM in the report "Progress in the Treatment of High-Risk Multiple Myeloma
Professor Zhang Fengchun gave a speech
Professor Zhang Fengchun reviewed the treatment challenges and explorations
of DLCBL in the report "Progress of DLBCL Treatment".
Professor Zhang Yaochen gave a report
Professor Zhang Yaochen of Shijiazhuang Ping'an Hospital shared the title "Clinical Research Application of Clinomycin in allo-HSCT"
Director Zhang Xian made a report
Director Zhang Xian of Lu Daopei Hospital shared the report
"Mechanism and Clinical Application of Cedarbenamide in the Treatment of Acute Leukemia" based on clinical cases.
Academic Report Session 2: Professor Da Wanming, Professor Wang Cunbang, Professor Li Dong, Professor Lu Peihua
Academic Report Session 3
Professor Liu Lihong gave a speech
Professor Liu Lihong of the Fourth Hospital of Hebei Medical University shared the report
"Progress in the diagnosis and treatment of follicular assisted T-cell lymphoma".
Professor Xiao Yang gave a report
Professor Xiao Yang of Jinshazhou Hospital of Guangzhou University of Chinese Medicine gave a report
entitled "Clinical Research Practice and Risk Management of Stem Cell Therapy".
Professor Li Yan gave a report
Professor Li Yan of the First Hospital of Handan City, Hebei Province shared the report
"AML 2022EHA New Progress of Acute Myeloid Leukemia".
Moderator and panelists: Professor Gao Da, Professor Shen Jianliang, Professor Ge Linfu
Academic Report Session 4
Professor Xiong Wenjie gave a report
Professor Xiong Wenjie of Guangzhou General Hospital of Qianhai Life Insurance shared the report
"Progress in Immunotherapy for Newly Diagnosed B-ALL in Adults".
Professor Wang Jianmin gave a speech
Professor Wang Jianmin of Lu Daopei Hospital shared the report
"Protection against Novel Coronavirus Infection in Patients with Blood Diseases" under the new situation of the epidemic.
Professor Jiang Min gave a report
Professor Jiang Min of Lu Daopei Hospital explained in detail what are the changes in the WHO-HEMA5 classification of "myeloid + histiocytes/dendritic cell tumors" in 2022? report
Director Shi Yuzhu made a report
Director Shi Yuzhu of Lu Daopei Hospital shared the report
"CT manifestations of air leakage syndrome after allogeneic hematopoietic stem cell transplantation" based on clinical cases.
Moderator and panelists: Professor Li Xinquan, Professor Liu Fang, Professor Wang Fuzhang, Professor Zheng Jin'e
The annual academic meeting of the Hematology Professional Committee of the China Association of Non-public Medical Institutions came to a successful conclusion
This academic annual meeting has built a platform for colleagues engaged in the field of hematology to communicate with each other, discuss new achievements, new progress and new trends in the field of hematology, and the participating experts and scholars will share their academic achievements and valuable clinical experience, so that the participants have gained a lot
The Second National Committee and the Second Standing Committee Meeting of the Second Special Committee
On the afternoon of November 4, 2022, the Second National Committee and Second Standing Committee Meeting of the Hematology Professional Committee of the China Association of Non-public Medical Institutions was successfully held
Wang Shan, Deputy Secretary-General of the Association and Director of the Member Organization Department, and all members of the Second Committee of the Special Committee attended the meeting
The meeting was chaired by Zhang Fengchun, vice chairman of the special committee
The meeting listened to Chairman Lu Peihua's report on the work of the special committee in 2022; discussed the next work plan of the Committee; 1 Standing Committee member and 4 additional members were added to the review; They listened to the briefings of Professor Liang Yingmin, Professor Ge Linfu and Professor Zhang Yaochen, members of the Standing Committee of the Special Committee, on the introduction of Xi'an International Medical Center Hospital, Jinan Hematology Hospital and Shijiazhuang Ping'an Hospital
Finally, Deputy Secretary-General Wang Shan made a report entitled "Giving Play to the Role of National Industry Organizations and Promoting the Positive Energy of Social Medical Service", and expressed opinions and suggestions
on the next step of the special committee's work.
Group photo of some online participants of the Second National Committee and the Second Standing Committee of the Hematology Professional Committee of the China Association of Non-public Medical Institutions
Since the establishment of the special committee five years ago, under the leadership of the general association, all members of the special committee have closely united, taught each other and made progress together, expanded new ideas and explored new ideas for the development of China's hematological cause and future research direction, and also let more patients with blood diseases see the hope
of long-term survival.
In the future, the special committee will further strengthen exchanges and cooperation with colleagues in the field of hematology, continuously gather strength, promote academic prosperity, bring hope to more patients with blood diseases, and contribute to a healthy China
After five years together, we are building the future together and look forward to meeting
again next year.